心脏占位性病变多模态影像学诊断研究进展
|
摘要
心脏占位性病变常发生于心脏各腔室及其相通大血管,来源复杂,分型繁多,多数起病隐匿、发作急骤,严重威胁患者生命。在心脏占位性病变的诊断、治疗及预后评估中,多模态影像学起到重要作用。本文主要对多模态影像学诊断心脏占位性病变的研究进展进行综述。
Cardiac masses with complicated sources and various classifications often locate on the walls and chambers of heart and interlink great vessels.Insidious onset and sudden appearance symptoms threaten the survival of patients.Multimodality imaging plays an important role in the fields of diagnosis,treatment and prognosis evaluation of cardiac masses.The advancements of multimodality imaging in diagnosis of cardiac masses were reviewed in this article.
Cardiac masses with complicated sources and various classifications often locate on the walls and chambers of heart and interlink great vessels.Insidious onset and sudden appearance symptoms threaten the survival of patients.Multimodality imaging plays an important role in the fields of diagnosis,treatment and prognosis evaluation of cardiac masses.The advancements of multimodality imaging in diagnosis of cardiac masses were reviewed in this article.
引文
[1] Burke A, Turke F. The 2015 WHO classification of tumors of the heart and pericardium. J Thorac Oncol, 2016,11(4):441-452.
[2] Zhang R, Li L, Li X, et al. Primary cardiac angiosarcoma: A case report. Medicine (Baltimore), 2017,96(42):e7352.
[3] Amano J, Nakayama J, Yoshimura Y, et al. Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences. Gen Thorac Cardiovasc Surg, 2013,61(8):435-447.
[4] Chowdhary A, Walpole S, Gupta S. A case of multiple cardiac calcified amorphous tumours. Indian Heart J, 2017,69(3):349-350.
[5] Motwani M, Kidambi A, Herzog B, et al. MR imaging of cardiac tumors and masses: A review of methods and clinical applications. Radiology, 2013,268(1):26-43.
[6] Neuville A, Collin F, Bruneval P, et al. Intimal sarcoma is the most frequent primary cardiac sarcoma: Clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol, 2014,38(4):461-469.
[7] Shuai H, Cao Y, Wei Q, et al. Prevalence of primary cardiac tumor malignancies in retrospective studies over six decades: A systematic review and meta-analysis. Oncotarget, 2017,8(26):43284-43294.
[8] Tumma R, Dong W, Wang J, et al. Evaluation of cardiac masses by CMR-strengths and pitfalls: A tertiary center experience. Int J Cardiovasc Imaging, 2016,32(6):913-920.
[9] 宁红艳,张虹.心脏肿瘤合并室性心动过速1例报告.吉林医学,2017,38(7):1396-1397.
[10] Burazor I, Avielronen S, Imazio M, et al. Primary malignancies of the heart and pericardium. Clin Cardiol, 2014,37(9):582-588.
[11] Dentamaro I, Vestito D, Michelotto E, et al. Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: From transthoracic to real time 3D transesophageal echocardiography. Int J Cardiovasc Imaging, 2017,33(4):491-498.
[12] Senior R, Becher H, Monaghan M, et al. Clinical practice of contrast echocardiography:Recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging, 2017,18(11):1205.
[13] Liang X, Gao J, Jiang L, et al. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. Acs Nano, 2015,9(2):1280-1293.
[14] 李宏州,杨晓峰.超声微泡造影剂在膀胱肿瘤中的研究进展.现代泌尿外科杂志,2017,22(5):389-391.
[15] Sasaki N, Bos C, Escoffre J, et al. Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration. Int J Pharm, 2015,482(1-2):118-122.
[16] Huynh E, Ben Y, Brandon L, et al. In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol, 2015,10(4):325-332.
[17] 杨露,成涓,陈瑜莉,等.光声/超声实时双模态显影纳米粒制备及示踪实验.中国介入影像与治疗学,2018,15(6):363-368.
[18] Jin Y, Ma X, Zhang S, et al. A tantalum oxide-based core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of esophageal carcinoma. Cancer Lett, 2017,397:61-71.
[19] Fathala A, Abouzied M, Alsugair A. Cardiac and pericardial tumors: A potential application of positron emission tomography-magnetic resonance imaging. World J Cardiol, 2017,9(7):600-608.
[20] Rahbar K, Seifarth H, Sch?fers M, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med, 2012,53(6):856-863.
[21] Studer A, Wechalekar K, Khattar R, et al. Histologically proven myocardial carcinoid metastases: The value of multimodality imaging. Can J Cardiol, 2017,33(10):1336.e9-1336.e12.
[22] Wong K, Waterfield R, Marzola M, et al. Contemporary nuclear medicine imaging of neuroendocrine tumours. Clin Radiol, 2012,67(11):1035-1050.
[23] Yaddanapudi K, Brunken R, Tan C, et al. PET-MR imaging in evaluation of cardiac and paracardiac masses with histopathologic correlation. JACC Cardiovasc Imaging, 2016,9(1):82-85.
[24] Campanile A, Tavazzi G, Alam MH, et al. An unexpected finding in an asymptomatic patient with atrial fibrillation: Cardiac angiosarcoma. Lancet, 2016,387(10036):e29.
[25] Murzi M, Miceli A, DiStefano G, et al. Minimally invasive right thoracotomy approach for mitral valve surgery in patients with previous sternotomy: A single institution experience with 173 patients. J Thorac Cardiovasc Surg, 2014,148(6):2763-2768.
[2] Zhang R, Li L, Li X, et al. Primary cardiac angiosarcoma: A case report. Medicine (Baltimore), 2017,96(42):e7352.
[3] Amano J, Nakayama J, Yoshimura Y, et al. Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences. Gen Thorac Cardiovasc Surg, 2013,61(8):435-447.
[4] Chowdhary A, Walpole S, Gupta S. A case of multiple cardiac calcified amorphous tumours. Indian Heart J, 2017,69(3):349-350.
[5] Motwani M, Kidambi A, Herzog B, et al. MR imaging of cardiac tumors and masses: A review of methods and clinical applications. Radiology, 2013,268(1):26-43.
[6] Neuville A, Collin F, Bruneval P, et al. Intimal sarcoma is the most frequent primary cardiac sarcoma: Clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol, 2014,38(4):461-469.
[7] Shuai H, Cao Y, Wei Q, et al. Prevalence of primary cardiac tumor malignancies in retrospective studies over six decades: A systematic review and meta-analysis. Oncotarget, 2017,8(26):43284-43294.
[8] Tumma R, Dong W, Wang J, et al. Evaluation of cardiac masses by CMR-strengths and pitfalls: A tertiary center experience. Int J Cardiovasc Imaging, 2016,32(6):913-920.
[9] 宁红艳,张虹.心脏肿瘤合并室性心动过速1例报告.吉林医学,2017,38(7):1396-1397.
[10] Burazor I, Avielronen S, Imazio M, et al. Primary malignancies of the heart and pericardium. Clin Cardiol, 2014,37(9):582-588.
[11] Dentamaro I, Vestito D, Michelotto E, et al. Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: From transthoracic to real time 3D transesophageal echocardiography. Int J Cardiovasc Imaging, 2017,33(4):491-498.
[12] Senior R, Becher H, Monaghan M, et al. Clinical practice of contrast echocardiography:Recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging, 2017,18(11):1205.
[13] Liang X, Gao J, Jiang L, et al. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. Acs Nano, 2015,9(2):1280-1293.
[14] 李宏州,杨晓峰.超声微泡造影剂在膀胱肿瘤中的研究进展.现代泌尿外科杂志,2017,22(5):389-391.
[15] Sasaki N, Bos C, Escoffre J, et al. Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration. Int J Pharm, 2015,482(1-2):118-122.
[16] Huynh E, Ben Y, Brandon L, et al. In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol, 2015,10(4):325-332.
[17] 杨露,成涓,陈瑜莉,等.光声/超声实时双模态显影纳米粒制备及示踪实验.中国介入影像与治疗学,2018,15(6):363-368.
[18] Jin Y, Ma X, Zhang S, et al. A tantalum oxide-based core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of esophageal carcinoma. Cancer Lett, 2017,397:61-71.
[19] Fathala A, Abouzied M, Alsugair A. Cardiac and pericardial tumors: A potential application of positron emission tomography-magnetic resonance imaging. World J Cardiol, 2017,9(7):600-608.
[20] Rahbar K, Seifarth H, Sch?fers M, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med, 2012,53(6):856-863.
[21] Studer A, Wechalekar K, Khattar R, et al. Histologically proven myocardial carcinoid metastases: The value of multimodality imaging. Can J Cardiol, 2017,33(10):1336.e9-1336.e12.
[22] Wong K, Waterfield R, Marzola M, et al. Contemporary nuclear medicine imaging of neuroendocrine tumours. Clin Radiol, 2012,67(11):1035-1050.
[23] Yaddanapudi K, Brunken R, Tan C, et al. PET-MR imaging in evaluation of cardiac and paracardiac masses with histopathologic correlation. JACC Cardiovasc Imaging, 2016,9(1):82-85.
[24] Campanile A, Tavazzi G, Alam MH, et al. An unexpected finding in an asymptomatic patient with atrial fibrillation: Cardiac angiosarcoma. Lancet, 2016,387(10036):e29.
[25] Murzi M, Miceli A, DiStefano G, et al. Minimally invasive right thoracotomy approach for mitral valve surgery in patients with previous sternotomy: A single institution experience with 173 patients. J Thorac Cardiovasc Surg, 2014,148(6):2763-2768.